Neucleus Group Limited (NEUC)

Neucleus Group Income Statement

Financials in millions USD. Fiscal year is July - June.

Year Ending	TTM	Jun 30, 2025	Jun 30, 2024
Revenue	4.56	3.1	0.27
Revenue Growth (YoY)	-	1030.42%	-
Cost of Revenue	-	0.83	0.08
Gross Profit	3.35	2.27	0.19
Selling, General & Admin	-	1.52	0.14
Other Operating Expenses	0	-0.51	-0
Operating Expenses	-	1.01	0.13
Operating Income	2.03	1.26	0.06
Interest Expense (Income)	0	0	-
Other Expense (Income)	-0	-0	-
Pretax Income	2.03	1.26	0.06
Income Tax	0.53	0.32	0
Net Income	1.51	0.94	0.05
Net Income Growth	-	1652.43%	-
Free Cash Flow	0.42	0.29	0.16
Gross Margin	73.55%	73.18%	69.99%
Operating Margin	44.62%	40.65%	20.78%
Profit Margin	33.06%	30.26%	19.52%
Free Cash Flow Margin	9.19%	9.33%	58.77%
Effective Tax Rate	25.91%	25.55%	6.05%
EBITDA	2.06	1.28	0.06
EBITDA Margin	45.27%	41.19%	20.78%
Depreciation & Amortization	0.03	0.02	-
EBIT	2.04	1.26	0.06
EBIT Margin	44.69%	40.70%	20.78%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).